斯坦德IPO：计划1.20亿元购买理财产品 手握现金2亿元却拟募资1.60亿元

Core Viewpoint - Stand Testing Group Co., Ltd. has received approval for its IPO application from the Beijing Stock Exchange, aiming to raise 160 million yuan for the development of a key common technology testing platform in life sciences [2] Group 1: Company Overview - Stand was established in 2014 and operates as an independent third-party testing and R&D service provider, offering services in inspection, analysis, calibration, certification, and judicial identification across various sectors including biomedicine, life health, ecological environment, and industrial trade [5] - As of the end of Q3 2025, Stand reported a cash balance of 200 million yuan and short-term interest-bearing loans of 45 million yuan, indicating a strong cash flow position with low short-term repayment pressure [5] Group 2: IPO Details - The IPO is sponsored by Zhongde Securities, with the application officially accepted [3] - The total investment for the proposed fundraising project is 309 million yuan, with construction costs of 296 million yuan and working capital of 13 million yuan, expected to generate annual revenue of 413 million yuan and total annual profit of 71 million yuan upon reaching production capacity [6] Group 3: Financial Management - In April 2025, Stand announced plans to use up to 120 million yuan of idle funds for purchasing bank wealth management products, prioritizing diversified cash management over immediate IPO financing needs [5] - Shortly before the IPO application, Stand executed a significant cash dividend distribution of 40.32 million yuan, representing 80.46% of the net profit attributable to shareholders after deducting non-recurring gains and losses for 2024 [5]